483
Biomat USA, IncBiomat USA, Inc – FDA 483, Feb 11, 2020
Record Details
An FDA inspection of Biotest USA, Inc.'s plasmapheresis center in Cincinnati, OH, identified two significant observations. The firm was cited for phlebotomists not adhering to standard operating procedures for arm scrubs, which could compromise the sterility of blood containers. Additionally, the facility failed to provide adequate private space for donor eligibility examinations, leading to donors standing in a crowded waiting area.
- Person
View Company Profile
ID · 89c24510-acda-4e21-823c-ce41409e2660
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.